Acelyrin Q4 EPS $(0.75) Beats $(0.99) Estimate

Acelyrin, Inc. +2.51%

Acelyrin, Inc.

SLRN

4.08

+2.51%

Acelyrin (NASDAQ: SLRN) reported quarterly losses of $(0.75) per share which beat the analyst consensus estimate of $(0.99) by 24.24 percent.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via